·
We'll be at ELRIG Cell & Gene Therapy 2026 at Hinxton Hall, Cambridge, UK on March 9-10.
The conference brings together researchers and developers working on engineering cancer immunotherapy and advances in T cell design and function. We'll be presenting a poster demonstrating the versatility of our AimGel artificial antigen-presenting cell platform, specifically showing how we can bias T cell expansion toward CD4 or CD8 subtypes through tuneable surface signal design.
This work showcases the flexibility of our hydrogel-based platform for precise control over T cell subset composition during expansion.
If you're attending ELRIG CGT 2026, we'd love to connect. Come find our poster and let's discuss how our platform can support your research.
